Cargando…

Data visualization explorer: A tool for participant representation in pivotal trials of FDA-approved medicinal products

This paper presents a 2015–2021 US Food and Drug Administration (FDA) Drug Trials Snapshots (DTS) Data Visualization Explorer—an interactive data visualization web-based tool (https://arielcarmeli.shinyapps.io/fda-drug-trial-snapshots-data-explorer) built in R and based on publicly available FDA cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carmeli, Ariel B., Meloney, Laura, Bierer, Barbara E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Descriptor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201200/ https://www.ncbi.nlm.nih.gov/pubmed/37223273 http://dx.doi.org/10.1016/j.patter.2023.100713

Ejemplares similares

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas
por: Machiela, Mitchell J., et al.
Publicado: (2023)

Predicting drug approvals: The Novartis data science and artificial intelligence challenge
por: Siah, Kien Wei, et al.
Publicado: (2021)

Wiz: A Web-Based Tool for Interactive Visualization of Big Data
por: Balzer, Christopher, et al.
Publicado: (2020)

Argonaut: A Web Platform for Collaborative Multi-omic Data Visualization and Exploration
por: Brademan, Dain R., et al.
Publicado: (2020)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Characteristics of pivotal clinical trials of FDA-approved endovascular devices between 2000 and 2018: An interrupted time series analysis
por: Moon, John T., et al.
Publicado: (2023)

Exploring anti-malarial potential of FDA approved drugs: an in silico approach
por: Ramakrishnan, Gayatri, et al.
Publicado: (2017)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

A Comprehensive Map of FDA-Approved Pharmaceutical Products
por: Zhong, Hao, et al.
Publicado: (2018)

Characteristics of Pivotal Trials and FDA Review of Innovative Devices
por: Rising, Joshua P., et al.
Publicado: (2015)

Impact of Nutrition or FDA-Approved Medicine Repurposing on Metabolic Syndrome and Diabetic Complications
por: Cai, Lu
Publicado: (2023)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)

Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA
por: Swanson, Matthew J., et al.
Publicado: (2021)

DUKweb, diachronic word representations from the UK Web Archive corpus
por: Tsakalidis, Adam, et al.
Publicado: (2021)

CVm6A: A Visualization and Exploration Database for m(6)As in Cell Lines
por: Han, Yujing, et al.
Publicado: (2019)

Quantitative analysis on the characteristics of targets with FDA approved drugs
por: Sakharkar, Meena K., et al.
Publicado: (2007)

FDA-Approved Natural Polymers for Fast Dissolving Tablets
por: Alam, Md Tausif, et al.
Publicado: (2014)

Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)

A systematic analysis of FDA-approved anticancer drugs
por: Sun, Jingchun, et al.
Publicado: (2017)

First vaccine approval under the FDA Animal Rule
por: Beasley, David W C, et al.
Publicado: (2016)

THPdb: Database of FDA-approved peptide and protein therapeutics
por: Usmani, Salman Sadullah, et al.
Publicado: (2017)

New FDA approved antibacterial drugs: 2015-2017
por: Andrei, Stefan, et al.
Publicado: (2018)

Immunotherapy for Breast Cancer: First FDA Approved Regimen
por: Soare, Georgiana R., et al.
Publicado: (2019)

Novel targeted drugs approved by the NMPA and FDA in 2019
por: Wang, Wenjing, et al.
Publicado: (2020)

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
por: Gherghescu, Ioana, et al.
Publicado: (2020)

FDA efficiency for approval process of COVID-19 therapeutics
por: Cassidy, Christine, et al.
Publicado: (2020)

Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
por: Shahid, Izza, et al.
Publicado: (2022)

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
por: Issa, Amalia M., et al.
Publicado: (2018)

Artificial Intelligence in Perioperative Medicine: A Proposed Common Language With Applications to FDA-Approved Devices
por: Melvin, Ryan L., et al.
Publicado: (2022)

Participation of Black US Residents in Clinical Trials of 24 Cardiovascular Drugs Granted FDA Approval, 2006-2020
por: Chen, Siliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_upsho017hd2vavc8krnn4ntmfs